Back
ESC Premium Access

Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts

Session: Novel therapies for heart failure in the early pipeline
Topic: Experimental Heart Failure
Speaker: Doctor A. Shiraki (Saga, JP)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aya Shiraki

Saga University, Saga (Japan)
0 follower

2 more presentations in this session

Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction

Speaker: Doctor M. Niewiadomska (Oklahoma City, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy

Speaker: Doctor T. Akira (Yokohama, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Novel therapies for heart failure in the early pipeline

Speakers: Doctor A. Shiraki, Doctor M. Niewiadomska, Doctor T. Akira
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources